Nektar Therapeutics
(NASDAQ:NKTR)
$1.29
-0.06[-4.44%]
Last update: 1:26PM Get Real Time Here
OverviewNewsEarningsGuidanceDividendsAnalyst RatingsInsider TradesShort Interest

Nektar Therapeutics Stock (NASDAQ:NKTR), Quotes and News Summary

Nektar Therapeutics Stock (NASDAQ: NKTR) stock price, news, charts, stock research, profile.

Open$1.320
Close-
Volume / Avg.1.551M / 2.333M
Day Range1.270 - 1.360
52 Wk Range0.413 - 1.750
Market Cap$236.867M
P/E Ratio-
Dividend Yield-
ExchangeNASDAQ
RSI
57
Short Interest
2.75%
Days to Cover2.38

Recent News

Why Bitdeer Technologies Shares Are Trading Higher By 10%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Shares of Bitdeer Technologies Group (NASDAQ: BTDR) rose sharply during Monday’s session after the company reported preliminary fourth-quarter financial results, announced the successful testing of its SEAL01 Bitcoin mining chip and amid overall strength in the price of Bitcoin.
Avi Kapoor
Why Krystal Biotech Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Gainers Vistagen Therapeutics, Inc. (NASDAQ: VTGN) shares jumped 747.6% to $14.24 after the company announced its Phase 3 PALISADE-2 trial evaluating the efficacy, safety, and tolerability of fasedienol met the primary and secondary endpoints.
Lisa Levin
Why Is Nektar Therapeutics Stock Surging Today?
Nektar Therapeutics Inc (NASDAQ: NKTR) said its former partner Eli Lilly And Co (NYSE: LLY) had presented "erroneous data" from two Phase 1b studies of its atopic dermatitis drug, 
Vandana Singh
-%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
1
1
Nov 23
0
0
0
0
Mar
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
2.2
Sell
Strong Buy
Buy
Hold
Sell
Strong Sell
About Nektar Therapeutics
Sector
Health Care
Industry
Pharmaceuticals
Nektar Therapeutics is a biopharmaceutical company. It has wholly-owned research and development pip...
Show More

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
NKTR
AVIR

FAQ

Q

How do I buy Nektar Therapeutics (NKTR) stock?

A

You can purchase shares of Nektar Therapeutics (NASDAQ: NKTR) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Nektar Therapeutics's (NKTR) competitors?

A

Other companies in Nektar Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS), Terns Pharma (NASDAQ:TERN) and Rani Therapeutics Hldgs (NASDAQ:RANI).

Q

What is the target price for Nektar Therapeutics (NKTR) stock?

A

The latest price target for Nektar Therapeutics (NASDAQ: NKTR) was reported by Jefferies on Wednesday, March 6, 2024. The analyst firm set a price target for 1.00 expecting NKTR to fall to within 12 months (a possible -23.66% downside). 5 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Nektar Therapeutics (NKTR)?

A

The stock price for Nektar Therapeutics (NASDAQ: NKTR) is $1.31 last updated Today at April 18, 2024 at 9:28 AM EDT.

Q

Does Nektar Therapeutics (NKTR) pay a dividend?

A

There are no upcoming dividends for Nektar Therapeutics.

Q

When is Nektar Therapeutics (NASDAQ:NKTR) reporting earnings?

A

Nektar Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Nektar Therapeutics (NKTR) going to split?

A

There is no upcoming split for Nektar Therapeutics.

Q

What sector and industry does Nektar Therapeutics (NKTR) operate in?

A

Nektar Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.

People Also Watch